NASDAQ:ARTLW 延时15分钟已退市

成交量

Connie L. Matsui: Connie L. Matsui is currently Chairman at Sutro Biopharma, Inc. since 2019 and Chairman at Artelo Biosciences, Inc. since 2017. Former roles include President & Chief Executive Officer at The San Diego Foundation from 2018 to 2019; Chairman-Collaboration & Senior Vice President at IDEC Pharmaceuticals Corp. from 1992 to 2004; Chairman & President at Girl Scouts of the USA from 1999 to 2002; Chairman at Balboa Park Conservancy; Independent Director at Halozyme Therapeutics, Inc. from 2011 to 2016; Executive Vice President-Knowledge & Innovation Networks at Biogen, Inc. from 2004 to 2009; Executive Vice President at Biogen Idec New Ventures, Inc. from 1992 to 2008; and EVP-Knowledge & Innovation Networks at Biogen Idec, Inc. (North Carolina) from 2004 to 2009. Education includes an undergraduate degree (1975) and an MBA (1977) from Stanford University.

Gregory D. Gorgas: Gregory D. Gorgas was the founder of Theragence, Inc., founded in 2009, where the title held was Managing Director from 2009 to 2011. Current jobs include President, CEO, Secretary & Director at Artelo Biosciences, Inc. starting in 2025; Director at Klotho Therapeutics, Inc.; and Director at Theragence, Inc. Former jobs include Senior Director-Global & United States Marketing at Biogen, Inc. from 2006 to 2008; Senior Vice President-Commercial & Corporate at Mast Therapeutics, Inc. from 2011 to 2017; and Senior Vice President-Commercial at Savara, Inc. Education includes undergraduate studies at The California State University and an MBA from the University of Phoenix.

Steven Kelly: Steven Kelly is the founder of CTx Operations, Inc., founded in 2018, serving as President, Chief Executive Officer & Director. Current jobs include Chief Executive Officer at Carisma Therapeutics, Inc. since 2025 and Independent Director at Artelo Biosciences, Inc. since 2017. Former jobs include President & Chief Executive Officer at Innovive Pharmaceuticals, Inc. from 2004 to 2010; President & Chief Executive Officer at Pinteon Therapeutics, Inc. from 2014 to 2015; Chief Executive Officer at Theracrine, Inc. from 2011 to 2012; President, Chief Executive Officer & Director at Carisma Therapeutics, Inc. from 2018 to 2025; Chief Commercial Officer at BioVex, Inc. from 2010 to 2011; and Principal at Kelly Bioconsulting LLC from 2012 to 2018. Education includes an MBA from Cornell University and an undergraduate degree from the University of Oregon.

Douglas W. Blayney: Douglas W. Blayney is the founder of Asco Quality Symposium. Current positions include Independent Director at Artelo Biosciences, Inc. since 2017 and Professor-Emeritus at Stanford University since 2010. Former positions include Medical Director and Professor-Internal Medicine at the University of Michigan Comprehensive Cancer Center from 1999 to 2003, Medical Director at Stanford Cancer Institute from 2010 to 2015, and President of the American Society of Clinical Oncology, Inc. from 2009 to 2010. Education includes undergraduate degrees from Stanford University and the University of California.

Robert Martin Emanuele: Robert Martin Emanuele was the founder of Synthrx, Inc., founded in 2008, where the title held was President & Chief Executive Officer from 2008 to 2010. Dr. Emanuele is also the founder of Visgenx, Inc... Dr. Emanuele currently holds the positions of President & Chief Executive Officer at Liferaft Biosciences, Inc., and Independent Director at Artelo Biosciences, Inc. since 2017. Former positions include Principal at EIDP, Inc.; Vice President-Research & Development at LadRx Corp. from 1988 to 2002; Vice President-Pharmaceutical Strategy at DaVita, Inc. from 2010 to 2011; Senior Vice President-Business Development at K mia, Inc. from 2006 to 2008; Chief Business Officer at Virobay, Inc.; Clinical Research Scientist at Dupont Critical Care, Inc.; VP-Corporate Development & Portfolio Management at Avanir Pharmaceuticals, Inc. from 2002 to 2006; Senior Vice President-Development at Mast Therapeutics, Inc. from 2011 to 2016; and Senior Vice President-Development at Savara, Inc. from 2011 to 2016. Education includes undergraduate studies at Colorado State University, an MBA from The University of Colorado, and a doctorate from Stritch School of Medicine.

Gregory R. Reyes: Gregory R. Reyes is the founder of Orox Biosciences, Inc., founded in 2017. Dr. Reyes currently serves as an Independent Director at Artelo Biosciences, Inc. since 2020. Former positions include Senior VP-Drug Discovery & Head-San Diego Site at Celgene Corp. from 2011 to 2016, Senior Vice President & Head-San Diego Site at Biogen, Inc. from 2008 to 2011, Vice President-Hepatitis Research at Genelabs Technologies, Inc., Vice President-Research & Development at Ingenex, Inc., Vice President-Molecular & Biological Research at Triplex Pharmaceutical Corp, Senior Vice President-Research at Bio Green Med Solution, Inc. from 2007 to 2008, VP-Biological Research & Infectious Diseases at Schering-Plough Research Institute, and Vice President-Discovery Biology at Pfizer (St. Louis). Education includes a doctorate from The Johns Hopkins University and an undergraduate degree from the University of California, Santa Cruz.

Tamara A. Favorito: Tamara A. Favorito is Chairman at Zevra Therapeutics, Inc. since 2023 and Independent Director at Artelo Biosciences, Inc. since 2021. Member of the California Society of Certified Public Accountants and The Association of Bioscience Financial Officers. Former roles include Independent Director at Kintara Therapeutics, Inc. from 2021 to 2024, Director at Beacon Discovery, Inc. from 2018 to 2021, Chief Financial Officer at Immunic, Inc. in 2019, Chief Financial Officer & Secretary at Signal Genetics, Inc. from 2014 to 2017, Chief Financial Officer at Viridian Therapeutics, Inc. from 2014 to 2017, Chief Financial Officer at HemaQuest Pharmaceuticals, Inc. from 2010 to 2014, Head-Favrille Transition Team at MMRGlobal, Inc. in 2009, Chief Financial Officer & Secretary at Favrille, Inc. from 2001 to 2009, Finance Director & Controller at Agouron Pharmaceuticals LLC from 1988 to 1991, Senior Audit Manager at PricewaterhouseCoopers LLP from 1980 to 1988, and Audit Manager at Deloitte & Touche LLP from 1980 to 1988. Education includes an MBA from Georgia State University and undergraduate studies at Valdosta State University.

Artelo Biosciences, Inc.